Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | -2.38% | 275.20 | 1.4% | $809.08m | |
| AMGN | Amgen, Inc. | -0.56% | 217.00 | 1.3% | $492.24m | |
| CELG | Celgene Corp. | -0.46% | 109.90 | 1.3% | $454.59m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 63.33 | 1.0% | $379.06m | |
| ILMN | Illumina, Inc. | 0.02% | 298.29 | 3.5% | $303.29m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.24% | 204.53 | 1.9% | $296.06m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.36% | 340.09 | 2.6% | $258.39m | |
| EXAS | EXACT Sciences Corp. | 2.09% | 79.89 | 24.0% | $198.96m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.62% | 105.40 | 2.0% | $180.23m | |
| SGEN | Seattle Genetics, Inc. | -0.13% | 112.06 | 6.1% | $131.37m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -0.71% | 75.60 | 4.3% | $115.42m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.38% | 97.59 | 14.6% | $111.53m | |
| A | Agilent Technologies, Inc. | -0.35% | 76.89 | 1.6% | $100.75m | |
| MRTX | Mirati Therapeutics, Inc. | 1.65% | 102.39 | 2.3% | $88.04m | |
| NBIX | Neurocrine Biosciences, Inc. | -1.18% | 109.60 | 5.0% | $84.66m |
Company Profile
Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.